Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

531
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
531
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

131
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
131
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

684
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
684
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

501
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
501
Inflammation01:38

Inflammation

52.5K
Overview
52.5K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

1.0K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and Molecular Genetic Risk Factors for Severe Familial Hypercholesterolemia.

Journal of lipid and atherosclerosis·2026
Same author

Treatment Target Discovery From Vasculo-Protective Phenotypes.

Journal of lipid and atherosclerosis·2026
Same author

Various Antihypertensive Drug Compliance Models and Cardiovascular Prognosis of People With Incidentally Detected High Blood Pressure During Health Check-Up in Korea.

International journal of hypertension·2026
Same author

The Emerging Lipid Risk: Lipoprotein(a).

Korean circulation journal·2025
Same author

Poor cardiovascular outcomes of underweight abdominal obesity in the entire population of newly diagnosed heart failure.

ESC heart failure·2025
Same author

Age-Dependent Role of Genetics and Renal Function for Atrial Fibrillation Development in Hypertrophic Cardiomyopathy.

Korean circulation journal·2025

Related Experiment Video

Updated: Jun 4, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K

Escalating Lipid Therapy After Achieving LDL-C <70 mg/dL With Moderate-Intensity Statins in High-Risk Patients.

Geunhee Park1, Eui-Young Choi2, Sang-Hak Lee3

  • 1Division of Cardiology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Korean Circulation Journal
|December 29, 2024
PubMed
Summary

Escalating lipid-lowering therapy (LLT) did not reduce major cardiovascular events or death in high-risk patients already at LDL-C targets. However, intensified treatment did lower rates of revascularization procedures.

Keywords:
Coronary artery diseaseDyslipidemiasHydroxymethylglutaryl-CoA reductase inhibitorsOutcome assessment, health care

More Related Videos

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.4K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K

Related Experiment Videos

Last Updated: Jun 4, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

14.6K
Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF
03:42

Author Spotlight: Exploring the Relationship Between Lipotoxicity and HFpEF

Published on: March 29, 2024

1.4K
LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

13.3K

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Current guidelines recommend target low-density lipoprotein cholesterol (LDL-C) levels and intensive lipid-lowering therapy (LLT) for high-risk individuals.
  • The benefit of intensifying LLT after achieving LDL-C targets with moderate-intensity statins remains unclear.

Purpose of the Study:

  • To evaluate the impact of escalating LLT on cardiovascular outcomes in patients with atherosclerotic cardiovascular disease (ASCVD) who have already met LDL-C goals (<70 mg/dL) on moderate-intensity statins.

Main Methods:

  • A retrospective propensity score-matched analysis of 1,315 ASCVD patients from two university hospitals (2006-2021).
  • Patients were categorized into LLT escalation (n=339) and non-escalation (n=976) groups.
  • Primary outcomes included major adverse cardiovascular and cerebrovascular events (MACCE1) and all-cause death.

Main Results:

  • No significant difference in MACCE1 rates (cardiovascular death, myocardial infarction, ischemic stroke) or all-cause death between groups after a median 5.7-year follow-up.
  • A significant reduction in MACCE2 rates (including revascularization) was observed in the LLT escalation group (HR, 0.70; p=0.017).

Conclusions:

  • Escalating LLT beyond moderate-intensity statins in ASCVD patients who have achieved LDL-C <70 mg/dL does not significantly reduce hard cardiovascular events or mortality.
  • Intensified LLT demonstrated a benefit in reducing the need for coronary or peripheral revascularization in this patient cohort.